This is a routine Form 144 filing for a CEO selling shares to cover tax obligations from vested equity awards. The sale represents a small fraction of total outstanding shares and is not indicative of a change in company outlook. Monitor for actual sale execution on Form 4, but no material impact expected.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5- T+0 · Nov 6 $34.84entry
- T+1 · 8d ago +3.19%α +0.82% · $35.95
- T+5 · 4d ago +3.85%α +1.25% · $36.18
- T+6 · todayOpen
- T+20 · in 20d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Progyny CEO Peter Anevski filed a Form 144 notice of intent to sell 90,000 shares of common stock, with an approximate market value of $2.71 million based on the filing. The shares were acquired through vesting of restricted stock units, performance stock units, and employee stock purchase plan grants from 2022 to early 2026. This is a routine insider sale of vested equity awards, not a secondary offering or open-market purchase.
Key Facts
- Insider: Peter Anevski, CEO and Director of Progyny, Inc.
- Shares to be sold: 90,000 shares of common stock
- Approximate value: $2,709,000 (based on filing date price of $30.10 per share)
- Shares acquired via vesting of RSUs, PSUs, and ESPP from 1/1/2022 to 3/3/2026
- Broker: Morgan Stanley Smith Barney LLC Executive Financial Services
- Proposed sale date: 11/05/2026 (same day as filing)
- Exchange: NASDAQ
Financial Impact
90,000 shares, approximately $2.71 million at filing price, representing about 0.12% of outstanding shares (based on 73.6M shares outstanding noted in filing)
Risk Factors
- CEO selling a material portion of his personal holdings could signal reduced alignment if the sale is larger than tax-related needs
- Form 144 is an intent to sell; the actual sale may not occur or may be at different prices
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-010740 |
| Document: 0001950047-26-010740-index.html | 0001950047-26-010740 |
| Document: 0001950047-26-010740.txt | 0001950047-26-010740 |
Track record
26 reports on PGNY
3 of 3 bullish or bearish reports moved the stock their way by T+5. Best: +6.43% at T+5 after the Nov 4, 2026 report. 3 of 4 went positive at some point.
Filters
- Nov 13, 20263d ago Insider Cluster Neutral 2/10 Entry $36.75 Now $37.15 +1.09% settles Nov 23
- Nov 12, 20264d ago Insider Cluster Bearish 4/10 Entry $36.18 Now $37.15 −2.68% settles Nov 20
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $36.58 Now $37.15 +1.56% settles Nov 19
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $36.50 Now $37.15 +1.78% settles Nov 18
- Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $36.43 Now $37.15 +1.98% settles Nov 17
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 2/10 Viewing Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 5, 202611d ago 144 Neutral 3/10 Entry $34.84 to $36.18 Now $37.15 +6.63% ▲ +3.85% +1.25% vs SPY
- Nov 4, 202612d ago 8-K Bullish 6/10 No price data
- Nov 4, 202612d ago Press Release Bullish 6/10 Entry $34.37 to $36.58 Now $37.15 +8.09% ▲ +6.43% +3.14% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers